维京医疗公司(Viking Therapeutics, Inc.)在盘后股价大跌6.75%,引发了市场的广泛关注。
公司今日公布2024年第四季度财报数据。根据财报显示,维京医疗当季每股亏损0.32美元,远高于分析师平均预期的每股亏损0.28美元。与去年同期相比,亏损也有28%的扩大。
财报数据不佳给市场带来了沉重打击。由于超过预期的亏损,可能引发了投资者对公司前景的担忧,并掀起了盘后抛售潮,令股价暴跌。然而,亏损扩大的具体原因目前仍不明确,我们有待进一步观察和分析。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.